Form 8-K · Current report
News Corp 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000162
Summary
News Corp bought back 62,323 Class A common shares for about US$1.75 million on July 28, 2026 under its 2025 Repurchase Program, which authorizes up to US$1 billion of Class A and Class B stock; cumulative purchases under the program total roughly US$391.3 million.
Key points
- News Corp is authorized to acquire up to an aggregate of US$1 billion of its Nasdaq-listed Class A and Class B common stock under the 2025 Repurchase Program, authorized as of July 15, 2025.
- On July 28, 2026 the company repurchased 62,323 Class A shares (ASX code NWSAA) for total consideration of approximately US$1,753,077, at prices between US$27.67 and US$28.27.
- Cumulative purchases under the 2025 Repurchase Program to date total approximately US$391.3 million.
- No ASX-listed CDIs will be repurchased under the program, and the buy-back is funded in USD for the stated purpose of enhancing shareholder value.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.